Laboratory Dry Granulator Market Growth Analysis, Trends, Key Players, Innovations, and Forecast 2025-2032The global laboratory dry granulator market size was valued at USD 59.4 million in 2024. The market is projected to grow from USD 63.2 million in 2025 to USD 89.7 million by 2032, exhibiting a CAGR of 6.1% during the forecast period.
A laboratory dry granulator is a specialized piece of equipment used for transforming powders into granules without liquid binders, primarily serving pharmaceutical, food, and chemical industries. This technology is critical for small-scale production, R&D, and formulation development, particularly for moisture-sensitive or heat-sensitive materials where traditional wet granulation is unsuitable.
The market growth is driven by increasing pharmaceutical R&D investments, projected to reach USD 260 billion globally by 2025, alongside stringent regulatory requirements for drug formulation consistency. While North America currently leads adoption due to strong biopharma sectors, Asia-Pacific shows the highest growth potential at 7.3% CAGR, fueled by expanding contract research organizations and generic drug manufacturing in India and China.The global laboratory dry granulator market is witnessing robust growth driven by increasing demand for efficient and precise granulation technologies in pharmaceutical and related industries. As pharmaceutical companies continue to invest heavily in research and development, the need for advanced dry granulation equipment that can handle moisture-sensitive and heat-sensitive compounds has become critical. Laboratory dry granulators offer a reliable, scalable, and cost-effective solution for producing consistent granules, essential for developing high-quality drug formulations. Additionally, growing regulatory emphasis on process consistency and quality control is further accelerating the adoption of dry granulation methods. With ongoing advancements in automation and process monitoring, the market is poised for significant expansion across regions, fueled by the pharmaceutical sector’s continuous innovation and stringent manufacturing standards.
Laboratory Dry Granulators: Enabling Precision in Particle Engineering
Laboratory dry granulators represent specialized equipment that transforms powders into uniform granules without liquid binders, addressing critical formulation challenges in pharmaceuticals, nutraceuticals, and specialty chemicals. Unlike conventional wet granulation systems, these instruments utilize mechanical compaction forces through roller compaction or slugging processes, making them indispensable for:
- Developing heat-sensitive compounds (biologics, certain APIs)
- Formulating moisture-reactive materials
- Small-scale R&D preceding commercial production
The technology’s significance has grown substantially as pharmaceutical companies increasingly adopt Quality by Design (QbD) principles, requiring precise control over particle characteristics from early development stages.
MARKET DYNAMICS MARKET DRIVERS
Growing Pharmaceutical R&D Expenditure to Fuel Market Expansion
The pharmaceutical industry’s increasing investment in research and development is a primary driver for the laboratory dry granulator market. With global pharmaceutical R&D spending reaching approximately $250 billion annually, companies are prioritizing formulation development and process optimization. Dry granulation has become essential for APIs and excipients sensitive to moisture or heat, with over 35% of new drug candidates requiring this technology during early-phase development. The ability to produce uniform granules without solvents makes lab-scale dry granulators indispensable for formulation scientists working on novel drug delivery systems and stability testing.
National Bureau of Statistics of China , According to preliminary estimates, China’s total expenditure on research and experimental development (R&D) exceeded 3.6 trillion yuan in 2024, registering 3.6130 trillion yuan, an increase of 8.3 percent over the previous year
Regulatory Emphasis on Process Consistency to Stimulate Adoption
Stringent quality requirements from regulatory agencies are accelerating the adoption of laboratory dry granulators. Current Good Manufacturing Practice (cGMP) guidelines emphasize robustness in formulation processes, making granule consistency a critical parameter. Recent data shows that nearly 42% of pharmaceutical process deviations originate during granulation, prompting companies to invest in precise lab-scale equipment for parameter optimization. The technology’s ability to maintain powder properties while improving flow characteristics aligns perfectly with regulatory expectations for reproducible manufacturing processes from early development stages.Regulatory bodies such as the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and other global authorities are increasingly emphasizing process consistency and quality control in pharmaceutical manufacturing.
MARKET OPPORTUNITIES
Emerging Markets Expansion to Create New Growth Avenues
Pharmaceutical industry growth in Asia-Pacific regions presents substantial opportunities for laboratory dry granulator manufacturers. Countries like India and China are increasing their spending on pharmaceutical R&D at rates exceeding 12% annually, creating demand for advanced formulation technologies. Local manufacturers transitioning toward regulated markets require equipment that can meet international quality standards, positioning laboratory dry granulators as critical investments for quality-focused emerging market players.
Continuous Manufacturing Adoption to Drive Innovation
The industry’s shift toward continuous manufacturing creates compelling opportunities for next-generation laboratory dry granulators. Recent regulatory endorsements of continuous processes emphasize the need for equipment that seamlessly transitions from development to production. Manufacturers integrating process analytical technology (PAT) into laboratory granulators enable real-time monitoring critical for continuous systems, while advanced machine learning algorithms help predict scale-up parameters more accurately than traditional empirical approaches.
List of Key Laboratory Dry Granulator Companies Profiled
- Fitzpatrick (U.S.)
- Hosokawa Micron (Japan)
- Alexanderwerk (Germany)
- Freund Corporation (Japan)
- Beijing LongliTech (China)
- GERTEIS (Switzerland)
- L.B. Bohle (Germany)
- Yenchen Machinery (Taiwan)
- WelchDry (U.S.)
- Cadmach (India)
- Canaan Technology (China)
- Bepex (Germany)
- Prism Pharma Machinery (India)
- KEYUAN (China)
- KaiChuang Machinery (China)
Segment Analysis:
By Capacity
Production Capacity 30-200Kg/Hour Segment Leads Due to Optimal Balance Between Efficiency and Flexibility
The market is segmented based on production capacity into:
- Production Capacity < 30Kg/Hour
- Primarily used in small-scale research laboratories and academic settings
- Production Capacity 30-200Kg/Hour
- Most popular segment for pharmaceutical formulation development
- Production Capacity > 200Kg/Hour
- Used in pilot plants and small-scale manufacturing facilities
By Application
Pharmaceutical Sector Dominates Market Demand Due to Extensive R&D Activities
The market is segmented based on application into:
- Pharmacy
- Drug formulation development
- Solid dosage form research
- Chemical Industry
- Specialty chemicals production
- Catalyst development
- Food
- Food additive research
- Nutritional supplement development
- Others
By Type
Roller Compaction Technology Remains Market Leader for Dry Granulation Processes
The market is segmented based on technology into:
- Roller Compaction
- Most widely adopted technology for pharmaceutical applications
- Slugging
- Traditional method suitable for smaller batches
- Advanced Dry Granulation
- Incorporates automation and process control features
By End User
Research Institutions Show Significant Adoption for Formulation Development
The market is segmented based on end user into:
- Pharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutions
- Food Technology Companies
- Chemical Manufacturers
Recent Developments
- Pharma R&D Adoption: Increasing use of compact dry granulators in laboratory-scale drug formulation for better reproducibility and faster development cycles.
- Continuous Manufacturing Integration: Equipment manufacturers are introducing dry granulators compatible with continuous processing lines, supporting regulatory push toward real-time quality assurance.
- Advanced Control Systems: Launch of systems with digital interfaces, PLC automation, and real-time process monitoring to improve precision and scalability.
- Material Versatility: New models are designed to handle highly potent APIs, moisture-sensitive compounds, and low-dose formulations, expanding application scope.
- Compact & Modular Designs: Rising demand for bench-top granulators that optimize lab space while allowing easy scale-up to pilot or production batches.
- Energy & Cost Efficiency: Manufacturers are focusing on reduced power consumption designs and low-maintenance rollers to meet sustainability and cost-control needs.
- Integration with PAT (Process Analytical Technology): Modern dry granulators now feature in-line sensors for monitoring particle size, density, and uniformity in real time.
- Global Expansion: Key players are expanding into Asia-Pacific and Latin America, where pharmaceutical manufacturing and academic R&D are accelerating.
- Collaborations & Acquisitions: Equipment suppliers are partnering with contract development and manufacturing organizations (CDMOs) and acquiring niche players to enhance market presence.
- Regulatory Alignment: New equipment releases are increasingly GMP-compliant and validated for FDA and EMA requirements, ensuring smooth lab-to-market transitions.
Purchase Full Report: Complete Market Forecast & Competitive Analysis
About Intel Market Research
Intel Market Research delivers actionable insights in technology and infrastructure markets. Our data-driven analysis leverages:
- Real-time infrastructure monitoring
- Techno-economic feasibility studies
Competitive intelligence across 100+ countries
Trusted by Fortune 500 firms, we empower strategic decisions with precision.
International: +1(332) 2424 294 | Asia: +91 9169164321
Website: https://www.intelmarketresearch.com
Follow us on LinkedIn: https://www.linkedin.com/company/intel-market-research
